Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV)
Journal article
Schilling WHK. et al, (2023), eLife, 12
Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study
Journal article
Mak WY. et al, (2023), British Journal of Clinical Pharmacology, 89, 330 - 339
Clinical antiviral efficacy of remdesivir and casirivimab/imdevimab against the SARS-CoV-2 Delta and Omicron variants
Preprint
Jittamala P. et al, (2022)
Systematic Review of Early Phase Pediatric Clinical Pharmacology Trials
Journal article
Subramanian D. et al, (2022), The Journal of Pediatric Pharmacology and Therapeutics, 27, 609 - 617
Pharmacometric assessment of the in vivo antiviral activity of ivermectin in early symptomatic COVID-19
Preprint
Schilling WHK. et al, (2022)
An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy
Journal article
Pérez Montilla CA. et al, (2021), Therapeutic Drug Monitoring, 43, 712 - 717
COVID-19 chemoprevention
Journal article
Cruz C. and White NJ., (2021), International Journal of Infectious Diseases, 107, 31 - 33
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Journal article
Schilling WHK. et al, (2020), Wellcome Open Research, 5, 241 - 241
Prevalence of UGT1A1 Genetic Variants in Argentinean Population, Potential Implications for Pharmacogenomic Testing
Preprint
Cruz CV. et al, (2019)
Are antihistamines effective in children?
Journal article
Cruz C. and Bournissen FG., (2016), Archivos Argentinos de Pediatria, 114